Moreover, DL models have proven to be beneficial over TMB, tumor-infiltrating lymphocytes (TILs) and PD-L1, and when combining with PD-L1, the AUC upgraded to 0.70 and the response rate to 51%, supporting multi model approach (62). This evidence concerns the gene CD274 and neoplasm.